504 related articles for article (PubMed ID: 25493974)
1. Very early administration of progesterone for acute traumatic brain injury.
Wright DW; Yeatts SD; Silbergleit R; Palesch YY; Hertzberg VS; Frankel M; Goldstein FC; Caveney AF; Howlett-Smith H; Bengelink EM; Manley GT; Merck LH; Janis LS; Barsan WG;
N Engl J Med; 2014 Dec; 371(26):2457-66. PubMed ID: 25493974
[TBL] [Abstract][Full Text] [Related]
2. A clinical trial of progesterone for severe traumatic brain injury.
Skolnick BE; Maas AI; Narayan RK; van der Hoop RG; MacAllister T; Ward JD; Nelson NR; Stocchetti N;
N Engl J Med; 2014 Dec; 371(26):2467-76. PubMed ID: 25493978
[TBL] [Abstract][Full Text] [Related]
3. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
5. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
Xiao G; Wei J; Yan W; Wang W; Lu Z
Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
[TBL] [Abstract][Full Text] [Related]
7. Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury.
Meyfroidt G; Taccone FS
Minerva Anestesiol; 2016 Apr; 82(4):486-91. PubMed ID: 26126980
[TBL] [Abstract][Full Text] [Related]
8. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.
Meythaler JM; Brunner RC; Johnson A; Novack TA
J Head Trauma Rehabil; 2002 Aug; 17(4):300-13. PubMed ID: 12105999
[TBL] [Abstract][Full Text] [Related]
9. Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy.
Narotam PK; Morrison JF; Nathoo N
J Neurosurg; 2009 Oct; 111(4):672-82. PubMed ID: 19463048
[TBL] [Abstract][Full Text] [Related]
10. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury.
Goldstein FC; Caveney AF; Hertzberg VS; Silbergleit R; Yeatts SD; Palesch YY; Levin HS; Wright DW
J Neurotrauma; 2017 Jan; 34(1):115-120. PubMed ID: 26973025
[TBL] [Abstract][Full Text] [Related]
11. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic temperature modulation in severe or moderate traumatic brain injury: a propensity score analysis of data from the Nationwide Japan Neurotrauma Data Bank.
Miyata K; Ohnishi H; Maekawa K; Mikami T; Akiyama Y; Iihoshi S; Wanibuchi M; Mikuni N; Uemura S; Tanno K; Narimatsu E; Asai Y
J Neurosurg; 2016 Feb; 124(2):527-37. PubMed ID: 26381247
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, severity classification, and outcome of moderate and severe traumatic brain injury: a prospective multicenter study.
Andriessen TM; Horn J; Franschman G; van der Naalt J; Haitsma I; Jacobs B; Steyerberg EW; Vos PE
J Neurotrauma; 2011 Oct; 28(10):2019-31. PubMed ID: 21787177
[TBL] [Abstract][Full Text] [Related]
14. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma.
Shakeri M; Boustani MR; Pak N; Panahi F; Salehpour F; Lotfinia I; Meshkini A; Daghighi S; vahedi P; Khani M; Taghiloo D
Clin Neurol Neurosurg; 2013 Oct; 115(10):2019-22. PubMed ID: 23871679
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Progesterone for Acute Traumatic Brain Injury: a Meta-analysis of Randomized Controlled Trials.
Wang Z; Shi L; Ding W; Shao F; Yu J; Zhang J
Mol Neurobiol; 2016 Dec; 53(10):7070-7077. PubMed ID: 26676571
[TBL] [Abstract][Full Text] [Related]
16. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.
Young B; Runge JW; Waxman KS; Harrington T; Wilberger J; Muizelaar JP; Boddy A; Kupiec JW
JAMA; 1996 Aug; 276(7):538-43. PubMed ID: 8709402
[TBL] [Abstract][Full Text] [Related]
17. "Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.
Gaab MR; Trost HA; Alcantara A; Karimi-Nejad A; Moskopp D; Schultheiss R; Bock WJ; Piek J; Klinge H; Scheil F
Zentralbl Neurochir; 1994; 55(3):135-43. PubMed ID: 7810251
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of traumatic brain injury in eastern China, 2004: a prospective large case study.
Wu X; Hu J; Zhuo L; Fu C; Hui G; Wang Y; Yang W; Teng L; Lu S; Xu G
J Trauma; 2008 May; 64(5):1313-9. PubMed ID: 18469656
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
[TBL] [Abstract][Full Text] [Related]
20. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
